Literature DB >> 14960213

The potential and limitations of personalised medicine in primary care.

Rhydian Hapgood.   

Abstract

Mesh：

Year:  2003        PMID： 14960213      PMCID： PMC1314742     

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN： 0960-1643            Impact factor:   5.386


× No keyword cloud information.
  16 in total

Review 1.  Ethical and legal implications of pharmacogenomics.

Authors:  M A Rothstein; P G Epps
Journal:  Nat Rev Genet       Date:  2001-03       Impact factor: 53.242

2.  CYP2D6 and CYP2C19 genotype-based dose recommendations for antidepressants: a first step towards subpopulation-specific dosages.

Authors:  J Kirchheiner; K Brøsen; M L Dahl; L F Gram; S Kasper; I Roots; F Sjöqvist; E Spina; J Brockmöller
Journal:  Acta Psychiatr Scand       Date:  2001-09       Impact factor: 6.392

3.  Anaesthetic deaths in a family.

Authors:  M A DENBOROUGH; J F FORSTER; R R LOVELL; P A MAPLESTONE; J D VILLIERS
Journal:  Br J Anaesth       Date:  1962-06       Impact factor: 9.166

4.  Efficacy and safety of trastuzumab as a single agent in first-line treatment of HER2-overexpressing metastatic breast cancer.

Authors:  Charles L Vogel; Melody A Cobleigh; Debu Tripathy; John C Gutheil; Lyndsay N Harris; Louis Fehrenbacher; Dennis J Slamon; Maureen Murphy; William F Novotny; Michael Burchmore; Steven Shak; Stanford J Stewart; Michael Press
Journal:  J Clin Oncol       Date:  2002-02-01       Impact factor: 44.544

5.  Mercaptopurine therapy intolerance and heterozygosity at the thiopurine S-methyltransferase gene locus.

Authors:  M V Relling; M L Hancock; G K Rivera; J T Sandlund; R C Ribeiro; E Y Krynetski; C H Pui; W E Evans
Journal:  J Natl Cancer Inst       Date:  1999-12-01       Impact factor: 13.506

Review 6.  Genetic epidemiology of environmental toxicity and cancer susceptibility: human allelic polymorphisms in drug-metabolizing enzyme genes, their functional importance, and nomenclature issues.

Authors:  D W Nebert; M Ingelman-Sundberg; A K Daly
Journal:  Drug Metab Rev       Date:  1999-05       Impact factor: 4.518

7.  Association of polymorphisms in the cytochrome P450 CYP2C9 with warfarin dose requirement and risk of bleeding complications.

Authors:  G P Aithal; C P Day; P J Kesteven; A K Daly
Journal:  Lancet       Date:  1999-02-27       Impact factor: 79.321

8.  Genetic variations in HLA-B region and hypersensitivity reactions to abacavir.

Authors:  Seth Hetherington; Arlene R Hughes; Michael Mosteller; Denise Shortino; Katherine L Baker; William Spreen; Eric Lai; Kirstie Davies; Abigail Handley; David J Dow; Mary E Fling; Michael Stocum; Clive Bowman; Linda M Thurmond; Allen D Roses
Journal:  Lancet       Date:  2002-03-30       Impact factor: 79.321

Review 9.  Pharmacogenetics and the practice of medicine.

Authors:  A D Roses
Journal:  Nature       Date:  2000-06-15       Impact factor: 49.962

Review 10.  Routinely administered questionnaires for depression and anxiety: systematic review.

Authors:  S M Gilbody; A O House; T A Sheldon
Journal:  BMJ       Date:  2001-02-17
View more
  4 in total

1.  Pharmacogenetics--expectations and reality.

Authors:  Geoff Tucker
Journal:  BMJ       Date:  2004-07-03

Review 2.  Pharmacogenetics, the next challenge for pharmacy?

Authors:  Jessica P Clemerson; Katherine Payne; Paul Bissell; Claire Anderson
Journal:  Pharm World Sci       Date:  2006-09-27

3.  Genetic epidemiology and primary care.

Authors:  Blair H Smith; Graham C M Watt; Harry Campbell; Aziz Sheikh
Journal:  Br J Gen Pract       Date:  2006-03       Impact factor: 5.386

4.  Generation Scotland: the Scottish Family Health Study; a new resource for researching genes and heritability.

Authors:  Blair H Smith; Harry Campbell; Douglas Blackwood; John Connell; Mike Connor; Ian J Deary; Anna F Dominiczak; Bridie Fitzpatrick; Ian Ford; Cathy Jackson; Gillian Haddow; Shona Kerr; Robert Lindsay; Mark McGilchrist; Robin Morton; Graeme Murray; Colin N A Palmer; Jill P Pell; Stuart H Ralston; David St Clair; Frank Sullivan; Graham Watt; Roland Wolf; Alan Wright; David Porteous; Andrew D Morris
Journal:  BMC Med Genet       Date:  2006-10-02       Impact factor: 2.103
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.